Alzheimers drug fails study but flashes potential

Alzheimer’s drug fails study but flashes potential

By TOM MURPHY The Associated Press
Published Aug 24, 2012 11:54AM MDT
Indianapolis • A possible Alzheimer’s disease treatment from drugmaker Eli Lilly missed the main goals of two late-stage studies, but the treatment showed some potential for slowing memory decline in patients with mild cases of the mind-robbing condition. Shares of the Lilly climbed Friday after the Indianapolis company announced what could be a step toward a long-awaited breakthrough in the fight against a disease that has no cure and ultimately proves fatal. But doctors and Lilly officials ca...
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share this post